Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies

NCT07196280 · clinicaltrials.gov ↗

COMPLETED

Status

10000

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)
Benign Prostatic Hypertrophy (BPH)

Interventions

DRUG: 5-Alpha Reductase Inhibitors

Sponsor

Chinese PLA General Hospital